Federal Register / Vol. 80, No. 57 / Wednesday, March 25, 2015 / Notices 15789 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than April 20, 2015. 

A. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. UMB Financial Corporation and 

Lakes Merger Sub LLC, both in Kansas 

City, Missouri; to acquire 100 percent of 

the voting shares of Marquette Financial 

Companies, Minneapolis, Minnesota, 

parent of Meridian Bank, National 

Association, Phoenix, Arizona, and 

Meridian Bank Texas, Fort Worth, 

Texas. Immediately thereafter, Lakes 

Merger Sub LLC will merge into UMB 

Financial Corporation. 

Board of Governors of the Federal Reserve 

System, March 20, 2015. 

Margaret McCloskey Shanks, 

Deputy Secretary of the Board. 

[FR Doc. 2015–06830 Filed 3–24–15; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF DEFENSE 

GENERAL SERVICES 

ADMINISTRATION 

NATIONAL AERONAUTICS AND 

SPACE ADMINISTRATION 

[OMB Control No. 9000–0054; Docket 2015– 

0053; Sequence 3] 

Federal Acquisition Regulation; 

Information Collection; U.S.-Flag Air 

Carriers Statement 

AGENCIES: Department of Defense (DOD), 

General Services Administration (GSA), 

and National Aeronautics and Space 

Administration (NASA). 

ACTION: Notice of request for public 

comments regarding an extension to an 

existing OMB clearance. 

SUMMARY: Under the provisions of the 

Paperwork Reduction Act, the 

Regulatory Secretariat will be 

submitting to the Office of Management 

and Budget (OMB) a request to review 

and approve a previously approved 

information collection requirement 

concerning U.S. Flag Air Carriers 

Statement. 

DATES: Submit comments on or before 

May 26, 2015. 

ADDRESSES: Submit comments 

identified by Information Collection 

9000–0054, U.S. Flag Air Carriers 

Statement by any of the following 

methods: 

• Regulations.gov: http://

www.regulations.gov. Submit comments 

via the Federal eRulemaking portal by 

searching the OMB control number 

9000–0054. Select the link ‘‘Comment 

Now’’ that corresponds with 

‘‘Information Collection ‘‘Information 

Collection 9000–0054, U.S. Flag Air 

Carriers Statement’’. Follow the 

instructions provided on the screen. 

Please include your name, company 

name (if any), and ‘‘Information 

Collection 9000–0054, U.S. Flag Air 

Carriers Statement’’ on your attached 

document. 

• Fax: 202–501–4067. 

• Mail: General Services 

Administration, Regulatory Secretariat 

Division (MVCB), 1800 F Street NW., 

Washington, DC 20405. ATTN: Ms. 

Hada Flowers/IC 9000–0054, U.S. Flag 

Air Carriers Statement. 

Instructions: Please submit comments 

only and cite Information Collection 

9000–0054, U.S. Flag Air Carriers 

Statement, in all correspondence related 

to this collection. All comments 

received will be posted without change 

to http://www.regulations.gov, including 

any personal and/or business 

confidential information provided. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Curtis E. Glover, Sr. Procurement 

Analyst, Contract Policy Division, GSA 

202–501–1448 or via email at 

curtis.glover@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

Section 5 of the International Air 

Transportation Fair Competitive 

Practices Act of 1974 (49 U.S.C. 1517) 

(Fly America Act) requires that all 

Federal agencies and Government 

contractors and subcontractors at FAR 

47.402, use U.S.-flag air carriers for U.S. 

Government-financed international air 

transportation of personnel (and their 

personal effects) or property, to the 

extent that service by those carriers is 

available. It requires the Comptroller 

General of the United States, in the 

absence of satisfactory proof of the 

necessity for foreign-flag air 

transportation, to disallow expenditures 

from funds, appropriated or otherwise 

established for the account of the United 

States, for international air 

transportation secured aboard a foreignflag air carrier if a U.S.-flag air carrier is 

available to provide such services. In 

the event that the contractor selects a 

carrier other than a U.S.-flag air carrier 

for international air transportation 

during performance of the contract, the 

contractor shall include per FAR clause 

52.247–64 a statement on vouchers 

involving such transportation. The 

contracting officer uses the information 

furnished in the statement to determine 

whether adequate justification exists for 

the contractor’s use of other than a U.S.- 

flag air carrier. 

B. Annual Reporting Burden 

Respondents: 150. 

Responses per Respondent: 2. 

Annual Responses: 300. 

Hours per Response: .25. 

Total Burden Hours: 75. 

C. Public Comments 

Public comments are particularly 

invited on: Whether this collection of 

information is necessary for the proper 

performance of functions of the FAR, 

and whether it will have practical 

utility; whether our estimate of the 

public burden of this collection of 

information is accurate, and based on 

valid assumptions and methodology; 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and ways in which we can 

minimize the burden of the collection of 

information on those who are to 

respond, through the use of appropriate 

technological collection techniques or 

other forms of information technology. 


rljohnson on DSK3VPTVN1PROD with NOTICES
15790 Federal Register / Vol. 80, No. 57 / Wednesday, March 25, 2015 / Notices 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the General Services Administration, 

Regulatory Secretariat Division (MVCB), 

1800 F Street NW., Washington, DC 

20405, telephone 202–501–4755. Please 

cite OMB Control No. 9000–0054, 

Submission for OMB Review; U.S.-Flag 

Air Carriers Statement, in all 

correspondence. 

Dated: March 19, 2015. 

Edward Loeb, 

Acting Director, Office of Government-wide 

Acquisition Policy, Office of Acquisition 

Policy, Office of Government-wide Policy. 

[FR Doc. 2015–06818 Filed 3–24–15; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Decision To Evaluate a Petition To 

Designate a Class of Employees From 

the Argonne National Laboratory-West 

in Scoville, Idaho, To Be Included in 

the Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services. 

ACTION: Notice. 

SUMMARY: NIOSH gives notice of a 

decision to evaluate a petition to 

designate a class of employees from the 

Argonne National Laboratory-West in 

Scoville, Idaho, to be included in the 

Special Exposure Cohort under the 

Energy Employees Occupational Illness 

Compensation Program Act of 2000. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 1090 Tusculum 

Avenue, MS C–46, Cincinnati, OH 

45226–1938, Telephone 877–222–7570. 

Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

SUPPLEMENTARY INFORMATION: 

Authority: 42 CFR 83.9–83.12. 

Pursuant to 42 CFR 83.12, the initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Argonne National 

Laboratory-West. 

Location: Scoville, Idaho. 

Job Titles and/or Job Duties: All 

workers who worked in any location. 

Period of Employment: April 10, 1951 

through December 31, 1979. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2015–06786 Filed 3–24–15; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 209 and 37 CFR part 404 to 

achieve expeditious commercialization 

of results of federally-funded research 

and development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

FOR FURTHER INFORMATION CONTACT: 

Licensing information and copies of the 

U.S. patent applications listed below 

may be obtained by writing to the 

indicated licensing contact at the Office 

of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301– 

496–7057; fax: 301–402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

SUPPLEMENTARY INFORMATION: 

Technology descriptions follow. 

Engineered Antibody Domains With 

Increased FcRn Binding and in vivo 

Half-Life 

Description of Technology: 

Monoclonal antibodies (mAbs) are a fast 

growing class of new therapeutic 

molecules. However, their large size 

remains a significant challenge, 

preventing them from targeting 

sterically restricted epitopes and 

efficiently penetrating into tissues. 

Smaller antibody fragments and 

engineered variants are under 

development to address this challenge, 

but to date their therapeutic 

applications have been limited due to 

rapid clearance and short half-life 

which greatly decrease their efficacy in 

vivo. 

This technology describes two 

antibody constant domains or binders 

with increased FcRn binding and in vivo 

half-life. In addition, these binders are 

small in size (16kDa), very stable, and 

can be efficiently expressed in E. coli. 

As a result, the binders are particularly 

well suited as scaffolds for the 

generation of antibody libraries, from 

which a desired antigen binders could 

be developed into therapeutic products 

with much greater potency compared to 

existing mAbs. They could also be used 

as fusion partners to extend the half-life 

of candidate protein therapeutics. 

Potential Commercial Applications 

• Antibody scaffolds for library 

construction, and the generation of 

therapeutics against various diseases. 

• Fusion partners to extend the halflife of candidate protein therapeutics. 

Competitive Advantages 

• Small (16kD) size for better tissue 

penetration, and in the case of fusion 

proteins, reduced steric hindrance for 

therapeutic activity. 

• Superior stability compared to 

isolated CH2 domains and stability 

comparable to or higher than that of an 

isolated Fc fragment. 

• Exhibit greatly enhanced FcRn 

binding abilities, including more potent 

transcytosis and longer in vivo half-life. 

• Can be efficiently expressed in E. 

coli. 

Development Stage 

• Early-stage 

• In vitro data available 

• In vivo data available (animal) 

Inventors: Dimiter Dimitrov and 

Tianlei Ying (NCI). 

Intellectual Property: HHS Reference 

No. E–136–2014/0—US Provisional 

Application No. 62/022,810 filed July 

10, 2014. 

Licensing Contact: Whitney Hastings, 

Ph.D.; 301–451–7337; hastingw@

mail.nih.gov. 

Collaborative Research Opportunity: 

The National Cancer Institute is seeking 

statements of capability or interest from 

parties interested in collaborative 

research to further develop, evaluate or 

commercialize Engineered Antibody 

Domains. For collaboration 

opportunities, please contact John D. 

Hewes, Ph.D. at john.hewes@nih.gov or 

240–276–5515. 

CXCR4 Reduction Leads to 

Enhancement of Engraftment of 

Hematopoietic Stem Cells 

Description of Technology: Methods 

of enhancing engraftment of donor 

hematopoietic stem cells (HSCs) by 

reducing expression or activity of 


rljohnson on DSK3VPTVN1PROD with NOTICES